Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Residual confounding threatens the validity of observational studies on breast cancer local therapy.

Jatoi I.

Cancer. 2020 Jan 30. doi: 10.1002/cncr.32741. [Epub ahead of print] No abstract available.

PMID:
31999835
2.

Epidemiologic Signatures in Cancer.

Jatoi I, Benson JR.

N Engl J Med. 2020 Jan 2;382(1):95-96. doi: 10.1056/NEJMc1914747. No abstract available.

PMID:
31875512
3.

Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression.

Chen G, Ding XF, Pressley K, Bouamar H, Wang B, Zheng G, Broome LE, Nazarullah A, Brenner AJ, Kaklamani V, Jatoi I, Sun LZ.

Clin Cancer Res. 2019 Dec 23. doi: 10.1158/1078-0432.CCR-19-2478. [Epub ahead of print]

PMID:
31871301
4.

The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology.

Jatoi I, Gail MH.

JAMA Oncol. 2019 Dec 12. doi: 10.1001/jamaoncol.2019.5361. [Epub ahead of print]

PMID:
31830235
5.

Extended endocrine therapy in early breast cancer: how long and who for?

Benson JR, Jatoi I.

Future Oncol. 2020 Jan;16(1):4327-4336. doi: 10.2217/fon-2019-0254. Epub 2019 Dec 5.

PMID:
31802715
6.

Factors related to re-excision procedures following primary breast-conserving surgery for women with breast cancer in the U.S. Military Health System.

Eaglehouse YL, Georg MW, Jatoi I, Shriver CD, Zhu K.

J Surg Oncol. 2019 Nov 29. doi: 10.1002/jso.25788. [Epub ahead of print]

PMID:
31784990
7.

Factors associated with genetic testing in a cohort of breast cancer survivors.

Blaes AH, Jewett PI, McKay K, Riley D, Jatoi I, Trentham-Dietz A, Chrischilles E, Klemp JR.

Breast J. 2019 Nov;25(6):1241-1244. doi: 10.1111/tbj.13440. Epub 2019 Jul 3.

PMID:
31270889
8.

BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells.

Zhang X, Wang Y, Chiang HC, Hsieh YP, Lu C, Park BH, Jatoi I, Jin VX, Hu Y, Li R.

Breast Cancer Res. 2019 Apr 17;21(1):51. doi: 10.1186/s13058-019-1132-1.

9.

BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells.

Chiang HC, Zhang X, Li J, Zhao X, Chen J, Wang HT, Jatoi I, Brenner A, Hu Y, Li R.

Nucleic Acids Res. 2019 Jun 4;47(10):5086-5099. doi: 10.1093/nar/gkz262.

10.

Surgical management of multiple ipsilateral breast cancers.

Benson JR, Jatoi I, Toi M.

Future Oncol. 2019 Apr;15(11):1185-1191. doi: 10.2217/fon-2019-0028. Epub 2019 Mar 29. No abstract available.

PMID:
30924355
11.

The history of cancer screening.

Jatoi I, Anderson WF, Miller AB, Brawley OW.

Curr Probl Surg. 2019 Apr;56(4):138-163. doi: 10.1067/j.cpsurg.2018.12.006. Epub 2019 Jan 14. No abstract available.

PMID:
30922446
12.

Clinical practice guidelines and the overuse of health care services: need for reform.

Jatoi I, Sah S.

CMAJ. 2019 Mar 18;191(11):E297-E298. doi: 10.1503/cmaj.181496. No abstract available.

PMID:
30885967
13.

Breast cancer over-diagnosis: an adverse consequence of mammography screening - highlights of the 2018 Kyoto Breast Cancer Consensus Conference.

Jatoi I, Benson JR, Toi M.

Future Oncol. 2019 Apr;15(11):1193-1196. doi: 10.2217/fon-2019-0027. Epub 2019 Mar 18. No abstract available.

PMID:
30880457
14.

Gestational gigantomastia.

Gerall CD, Jatoi I.

Surgery. 2019 Feb;165(2):485. doi: 10.1016/j.surg.2018.09.019. Epub 2018 Oct 30. No abstract available.

PMID:
30389173
15.

Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.

Jatoi I.

Eur J Breast Health. 2018 Oct 1;14(4):189-193. doi: 10.5152/ejbh.2018.4324. eCollection 2018 Oct. Review.

16.

Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers.

Winters ZE, Horsnell J, Elvers KT, Maxwell AJ, Jones LJ, Shaaban AM, Schmid P, Williams NR, Beswick A, Greenwood R, Ingram JC, Saunders C, Vaidya JS, Esserman L, Jatoi I, Brunt AM.

BJS Open. 2018 May 22;2(4):162-174. doi: 10.1002/bjs5.53. eCollection 2018 Aug. Review.

17.

Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 2).

Benson JR, Jatoi I.

Future Oncol. 2018 Aug;14(19):1893-1896. doi: 10.2217/fon-2018-0184. Epub 2018 Jul 18.

PMID:
30019940
18.

Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1).

Benson JR, Jatoi I.

Future Oncol. 2018 Aug;14(19):1889-1892. doi: 10.2217/fon-2018-0185. Epub 2018 Jul 18.

PMID:
30019918
19.

Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality?

Jatoi I, Benson JR, Kunkler I.

NPJ Breast Cancer. 2018 Apr 3;4:8. doi: 10.1038/s41523-018-0061-y. eCollection 2018. Review.

20.

Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.

Zhang X, Chiang HC, Wang Y, Zhang C, Smith S, Zhao X, Nair SJ, Michalek J, Jatoi I, Lautner M, Oliver B, Wang H, Petit A, Soler T, Brunet J, Mateo F, Angel Pujana M, Poggi E, Chaldekas K, Isaacs C, Peshkin BN, Ochoa O, Chedin F, Theoharis C, Sun LZ, Curiel TJ, Elledge R, Jin VX, Hu Y, Li R.

Nat Commun. 2018 Mar 30;9:16211. doi: 10.1038/ncomms16211.

21.

Surgical management of the axilla in early breast cancer.

Jatoi I, Benson JR.

Curr Probl Surg. 2018 Feb;55(2):47-65. doi: 10.1067/j.cpsurg.2018.01.003. Epub 2018 Feb 2. Review. No abstract available.

PMID:
29555055
22.

Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System.

Shao S, Gill AA, Zahm SH, Jatoi I, Shriver CD, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):50-57. doi: 10.1158/1055-9965.EPI-17-0439. Epub 2017 Nov 2.

23.

Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2.

Benson JR, Jatoi I.

Future Oncol. 2017 Jul;13(16):1365-1369. doi: 10.2217/fon-2017-0089. Epub 2017 Jul 7.

24.

Highlights of the San Antonio Breast Cancer Symposium 2016.

Benson JR, Jatoi I.

Future Oncol. 2017 Jun;13(15):1291-1295. doi: 10.2217/fon-2017-0088. Epub 2017 Jun 26.

25.

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.

Zhang X, Chiang HC, Wang Y, Zhang C, Smith S, Zhao X, Nair SJ, Michalek J, Jatoi I, Lautner M, Oliver B, Wang H, Petit A, Soler T, Brunet J, Mateo F, Angel Pujana M, Poggi E, Chaldekas K, Isaacs C, Peshkin BN, Ochoa O, Chedin F, Theoharis C, Sun LZ, Curiel TJ, Elledge R, Jin VX, Hu Y, Li R.

Nat Commun. 2017 Jun 26;8:15908. doi: 10.1038/ncomms15908. Erratum in: Nat Commun. 2018 Mar 30;9:16211.

26.

Reconsidering axillary surgery for early breast cancer.

Jatoi I.

Indian J Med Res. 2017 Feb;145(2):155-157. doi: 10.4103/ijmr.IJMR_1837_16. No abstract available.

27.

Breast-Cancer Tumor Size and Screening Effectiveness.

Jatoi I, Anderson WF.

N Engl J Med. 2017 Jan 5;376(1):93. No abstract available.

PMID:
28060474
28.

Treatment of low-risk ductal carcinoma in situ: is nothing better than something?

Benson JR, Jatoi I, Toi M.

Lancet Oncol. 2016 Oct;17(10):e442-e451. doi: 10.1016/S1470-2045(16)30367-9. Review.

PMID:
27733270
29.

De-escalation of axillary surgery in early breast cancer.

Jatoi I, Benson JR, Toi M.

Lancet Oncol. 2016 Oct;17(10):e430-e441. doi: 10.1016/S1470-2045(16)30311-4. Review.

PMID:
27733269
30.

Management of women with a hereditary predisposition for breast cancer.

Jatoi I, Benson JR.

Future Oncol. 2016 Oct;12(19):2277-88. doi: 10.2217/fon-2016-0186. Epub 2016 Jul 7. Review.

PMID:
27384952
31.

Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing Trend.

Jatoi I.

Indian J Surg Oncol. 2015 Dec;6(4):387-9. doi: 10.1007/s13193-015-0450-8. Epub 2015 Aug 1.

32.

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Mullooly M, Pfeiffer RM, Nyante SJ, Heckman-Stoddard BM, Perloff M, Jatoi I, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Berrington de Gonzalez A, Sherman ME, Gierach GL.

J Clin Oncol. 2016 Jun 20;34(18):2093-7. doi: 10.1200/JCO.2015.64.4492. Epub 2016 Mar 28. No abstract available.

33.

Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.

Brown D, Shao S, Jatoi I, Shriver CD, Zhu K.

Cancer Epidemiol. 2016 Jun;42:24-31. doi: 10.1016/j.canep.2016.02.011. Epub 2016 Mar 18.

PMID:
26999400
34.

Highlights of the San Antonio Breast Cancer Symposium 2015: part 1.

Benson JR, Jatoi I.

Future Oncol. 2016 Apr;12(7):893-6. doi: 10.2217/fon-2016-0043. Epub 2016 Feb 15. Erratum in: Future Oncol. 2016 May;12(9):1206.

35.

Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.

Benson JR, Jatoi I.

Future Oncol. 2016 Apr;12(7):897-900. doi: 10.2217/fon-2016-0044. Epub 2016 Feb 15.

36.

Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?

Winters ZE, Horsnell J, Schmid P, Jones JL, Shaaban A, Maxwell AJ, Williams N, Esserman L, Jatoi I, Brunt AM; MIAMI (Multiple Ipsilateral breast conserving surgery versus mastectomy) Trial Management Group.

Breast. 2016 Apr;26:149-50. doi: 10.1016/j.breast.2015.12.011. Epub 2016 Feb 3. No abstract available.

PMID:
26851965
37.

Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy.

Jatoi I, Bandos H, Jeong JH, Anderson WF, Romond EH, Mamounas EP, Wolmark N.

J Natl Cancer Inst. 2015 Oct 30;108(1). pii: djv304. doi: 10.1093/jnci/djv304. Print 2016 Jan.

38.

Breast Cancer Screening in Elderly Women: Primum Non Nocere.

Jatoi I, Miller AB.

JAMA Surg. 2015 Dec;150(12):1107-8. doi: 10.1001/jamasurg.2015.2663. Review. No abstract available.

PMID:
26465234
39.

Breast-Cancer Screening--Viewpoint of the IARC Working Group.

Jatoi I.

N Engl J Med. 2015 Oct 8;373(15):1478-9. doi: 10.1056/NEJMc1508733. No abstract available.

PMID:
26444744
40.

Breast cancer screening: past, present and future.

Jatoi I.

Future Oncol. 2015 Oct;11(19):2621-2624. doi: 10.2217/fon.15.209. Epub 2015 Sep 4. No abstract available.

PMID:
26338534
41.

Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells.

Hsu PY, Hsu HK, Hsiao TH, Ye Z, Wang E, Profit AL, Jatoi I, Chen Y, Kirma NB, Jin VX, Sharp ZD, Huang TH.

Oncogene. 2016 May 5;35(18):2379-89. doi: 10.1038/onc.2015.298. Epub 2015 Aug 24.

42.

Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W Jr, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P.

Rev Recent Clin Trials. 2015;10(3):206-11. Review.

PMID:
26238119
43.

Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers.

Chiang HC, Elledge R, Larson P, Jatoi I, Li R, Hu Y.

Breast Cancer (Auckl). 2015 Jun 2;9:25-9. doi: 10.4137/BCBCR.S26774. eCollection 2015.

44.

Mammography: review of the controversy, health disparities, and impact on young african american women.

Kidd AD, Colbert AM, Jatoi I.

Clin J Oncol Nurs. 2015 Jun;19(3):E52-8. doi: 10.1188/15.CJON.E52-E58. Review.

PMID:
26000591
45.

Personalization of loco-regional care for primary breast cancer patients (part 2).

Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I, Sasano H, Kunkler I, Ho AY, Yamauchi C, Chow LW, Huang CS, Han W, Noguchi S, Pegram MD, Yamauchi H, Lee ES, Larionov AA, Bevilacqua JL, Yoshimura M, Sugie T, Yamauchi A, Krop IE, Noh DY, Klimberg VS; 2014 Kyoto Breast Cancer Consensus Conference.

Future Oncol. 2015;11(9):1301-5. doi: 10.2217/fon.15.66.

46.

Personalization of loco-regional care for primary breast cancer patients (part 1).

Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I, Sasano H, Kunkler I, Ho AY, Yamauchi C, Chow LW, Huang CS, Han W, Noguchi S, Pegram MD, Yamauchi H, Lee ES, Larionov AA, Bevilacqua JL, Yoshimura M, Sugie T, Yamauchi A, Krop IE, Noh DY, Klimberg VS; 2014 Kyoto Breast Cancer Consensus Conference.

Future Oncol. 2015;11(9):1297-300. doi: 10.2217/fon.15.65.

47.

Postmastectomy radiotherapy in patients with breast cancer.

Jatoi I.

Lancet. 2014 Nov 22;384(9957):1844-1845. doi: 10.1016/S0140-6736(14)62237-6. Epub 2014 Nov 21. No abstract available.

PMID:
25457911
48.

Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.

Jatoi I, Parsons HM.

Breast Cancer Res Treat. 2014 Nov;148(2):389-96. doi: 10.1007/s10549-014-3160-y. Epub 2014 Oct 10.

49.

A historical account of breast cancer surgery: beware of local recurrence but be not radical.

Halsted CP, Benson JR, Jatoi I.

Future Oncol. 2014;10(9):1649-57. doi: 10.2217/fon.14.98. Review.

PMID:
25145433
50.

Management of the clinically node-negative axilla in primary and locally recurrent breast cancer.

McGinity AC, Lautner MA, Jatoi I.

Surg Oncol Clin N Am. 2014 Jul;23(3):463-71. doi: 10.1016/j.soc.2014.03.010. Epub 2014 Apr 14. Review.

PMID:
24882345

Supplemental Content

Support Center